-
1
-
-
0038653525
-
A meta-analysis of the efficacy of secondgeneration antipsychotics
-
Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of secondgeneration antipsychotics. Arch Gen Psychiatry. 2003;60:553-564.
-
(2003)
Arch Gen Psychiatry
, vol.60
, pp. 553-564
-
-
Davis, J.M.1
Chen, N.2
Glick, I.D.3
-
2
-
-
0346120179
-
Efficacy and effectiveness of first- and secondgeneration antipsychotics in schizophrenia
-
Jaffe AB, Levine J. Efficacy and effectiveness of first- and secondgeneration antipsychotics in schizophrenia. J Clin Psychiatry. 2003;64(suppl 17):3-6.
-
(2003)
J Clin Psychiatry
, vol.64
, Issue.SUPPL. 17
, pp. 3-6
-
-
Jaffe, A.B.1
Levine, J.2
-
3
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
-
Lieberman JA, Stroup TS, McEvoy JP, et al. for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
-
(2005)
N Engl J Med
, vol.353
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
-
4
-
-
34548586774
-
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder
-
Dunayevich E, Ascher-Svanum H, Zhao F, et al. Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder. J Clin Psychiatry. 2007;64:1163-1171.
-
(2007)
J Clin Psychiatry
, vol.64
, pp. 1163-1171
-
-
Dunayevich, E.1
Ascher-Svanum, H.2
Zhao, F.3
-
5
-
-
0035002177
-
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder
-
Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2001;158:765-774.
-
(2001)
Am J Psychiatry
, vol.158
, pp. 765-774
-
-
Conley, R.R.1
Mahmoud, R.2
-
6
-
-
0030770872
-
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
-
Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol. 1997;17:407-418.
-
(1997)
J Clin Psychopharmacol
, vol.17
, pp. 407-418
-
-
Tran, P.V.1
Hamilton, S.H.2
Kuntz, A.J.3
-
7
-
-
23944442440
-
Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
-
Dossenbach M, Arango-Davila C, Ibarra HS, et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. J Clin Psychiatry. 2005;66:1021-1030.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1021-1030
-
-
Dossenbach, M.1
Arango-Davila, C.2
Ibarra, H.S.3
-
8
-
-
33747185865
-
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalization due to schizophrenia and schizoaffective disorder: Observational follow-up study
-
Tiihonen J, Wahlbeck K, Lonnqvist J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalization due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ. 2006;333:224-227.
-
(2006)
BMJ
, vol.333
, pp. 224-227
-
-
Tiihonen, J.1
Wahlbeck, K.2
Lonnqvist, J.3
-
9
-
-
33744795750
-
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia
-
Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry. 2006;67(suppl 5):3-8.
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 5
, pp. 3-8
-
-
Leucht, S.1
Heres, S.2
-
11
-
-
0036773689
-
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
-
Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892-909.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 892-909
-
-
Lacro, J.P.1
Dunn, L.B.2
Dolder, C.R.3
-
12
-
-
3042576182
-
Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors
-
Valenstein M, Blow FC, Copeland LA, et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004;30:255-264.
-
(2004)
Schizophr Bull
, vol.30
, pp. 255-264
-
-
Valenstein, M.1
Blow, F.C.2
Copeland, L.A.3
-
13
-
-
0141841720
-
Risk adjustment in studies using administrative data
-
Sernyak MJ, Rosenheck R. Risk adjustment in studies using administrative data. Schizophr Bull. 2003;29:267-271.
-
(2003)
Schizophr Bull
, vol.29
, pp. 267-271
-
-
Sernyak, M.J.1
Rosenheck, R.2
-
14
-
-
0036712784
-
From conventional to atypical antipsychotics and back: Dynamic processes in the diffusion of new medications
-
Douglas LL, Rosenheck RA. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. Am J Psychiatry. 2002;159:1534-1540.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 1534-1540
-
-
Douglas, L.L.1
Rosenheck, R.A.2
-
15
-
-
0036773676
-
Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder
-
Robinson DG, Woerner MG, Alvir JMJ, et al. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res. 2002;57:209-221.
-
(2002)
Schizophr Res
, vol.57
, pp. 209-221
-
-
Robinson, D.G.1
Woerner, M.G.2
Alvir, J.M.J.3
-
16
-
-
0036187764
-
Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996
-
Mojtabai R, Lavelle J, Gibson PJ, et al. Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatr Serv. 2002;53:337-339.
-
(2002)
Psychiatr Serv
, vol.53
, pp. 337-339
-
-
Mojtabai, R.1
Lavelle, J.2
Gibson, P.J.3
|